🇺🇸 FDA
Pipeline program

VTP-1000

GLU001

Phase 1 mab active

Quick answer

VTP-1000 for Celiac Disease is a Phase 1 program (mab) at Barinthus Biotherapeutics plc. with 1 ClinicalTrials.gov record(s).

Program details

Company
Barinthus Biotherapeutics plc.
Indication
Celiac Disease
Phase
Phase 1
Modality
mab
Status
active

Clinical trials